Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

United Therapeutics (NASDAQ:UTHR) Director Sells $495,950.00 in Stock

Summary by marketbeat.com
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Patusky sold 1,000 shares of the firm's stock in a transaction on Monday, December 15th. The shares were sold at an average price of $495.95, for a total transaction of $495,950.00. Following the sale, the director owned 1,490 shares in the company, valued at approximately $738,965.50. This trade represents a 40.16% decrease in their position. The transaction wa…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Tuesday, December 16, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal